 If any indication of the presence of a cancer, tumorigenic process, or general sign of ill-health is observed, the protocol calls for a discussion of the findings among the research team, followed by a discussion between the clinical lead on the research team and the primary care provider andor specialists overseeing a participating patients care, possible validation of the assays motivating the discussions, and a decision on how to intervene on the part of the primary care provider andor specialists. 